ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04724	Glutamatergic synapse	25/206	152/7206	7.07992874002e-13
ko04080	Neuroactive ligand-receptor interaction	39/206	423/7206	3.76087756196e-11
ko04020	Calcium signaling pathway	27/206	265/7206	6.51299639285e-09
ko04728	Dopaminergic synapse	21/206	185/7206	5.50687914939e-08
ko05031	Amphetamine addiction	14/206	91/7206	2.40105047149e-07
ko05033	Nicotine addiction	11/206	56/7206	3.84724457279e-07
ko04727	GABAergic synapse	15/206	110/7206	4.47854779504e-07
ko05030	Cocaine addiction	12/206	73/7206	8.58285736527e-07
ko04911	Insulin secretion	15/206	117/7206	1.00789869622e-06
ko04072	Phospholipase D signaling pathway	19/206	197/7206	3.02893745716e-06
ko04720	Long-term potentiation	13/206	99/7206	4.1378469591e-06
ko04723	Retrograde endocannabinoid signaling	17/206	175/7206	9.32559538903e-06
ko04022	cGMP-PKG signaling pathway	19/206	216/7206	1.16909801289e-05
ko04725	Cholinergic synapse	16/206	160/7206	1.19296633667e-05
ko05032	Morphine addiction	13/206	110/7206	1.34458843843e-05
ko04713	Circadian entrainment	14/206	136/7206	3.07126183926e-05
ko04726	Serotonergic synapse	14/206	137/7206	3.33571363584e-05
ko04024	cAMP signaling pathway	21/206	279/7206	4.31660530431e-05
ko04915	Estrogen signaling pathway	13/206	131/7206	8.68450297729e-05
ko04360	Axon guidance	18/206	233/7206	0.000111550690476
ko04261	Adrenergic signaling in cardiomyocytes	16/206	205/7206	0.000240541641556
ko04972	Pancreatic secretion	11/206	111/7206	0.000308941971785
ko05231	Choline metabolism in cancer	12/206	134/7206	0.000425839913707
ko04211	Longevity regulating pathway	11/206	123/7206	0.000746128095554
ko04925	Aldosterone synthesis and secretion	10/206	105/7206	0.000793190277335
ko04921	Oxytocin signaling pathway	15/206	209/7206	0.000909189542377
ko04070	Phosphatidylinositol signaling system	10/206	112/7206	0.00130861499418
ko04970	Salivary secretion	9/206	95/7206	0.00149870034043
ko04923	Regulation of lipolysis in adipocytes	8/206	77/7206	0.00150759210767
ko04371	Apelin signaling pathway	13/206	177/7206	0.0016141468142
ko04742	Taste transduction	7/206	61/7206	0.00165950964669
ko05213	Endometrial cancer	7/206	62/7206	0.00182626706003
ko04015	Rap1 signaling pathway	17/206	278/7206	0.00271647446761
ko04010	MAPK signaling pathway	19/206	321/7206	0.00279866136313
ko04213	Longevity regulating pathway - multiple species	8/206	86/7206	0.00305471734182
ko04540	Gap junction	10/206	128/7206	0.00353397216477
ko04012	ErbB signaling pathway	9/206	109/7206	0.00385874120112
ko05414	Dilated cardiomyopathy	9/206	112/7206	0.00462132926255
ko04062	Chemokine signaling pathway	13/206	201/7206	0.007592477637
ko04912	GnRH signaling pathway	9/206	122/7206	0.00803696137395
ko00512	Mucin type O-glycan biosynthesis	4/206	29/7206	0.00879541948211
ko05034	Alcoholism	14/206	238/7206	0.00900067611031
ko01521	EGFR tyrosine kinase inhibitor resistance	8/206	106/7206	0.0107039600256
ko05223	Non-small cell lung cancer	6/206	66/7206	0.011084973034
ko04924	Renin secretion	7/206	86/7206	0.0112371834258
ko00562	Inositol phosphate metabolism	7/206	89/7206	0.0134177282272
ko00510	N-Glycan biosynthesis	5/206	50/7206	0.0135725496554
ko04139	Mitophagy - yeast	4/206	37/7206	0.0204950380663
ko04971	Gastric acid secretion	7/206	98/7206	0.0217634658359
ko04666	Fc gamma R-mediated phagocytosis	8/206	122/7206	0.0232706096736
ko04730	Long-term depression	6/206	78/7206	0.0236841310574
ko05214	Glioma	6/206	79/7206	0.0250420336441
ko05203	Viral carcinogenesis	2/206	277/7206	0.025309390638
ko01522	Endocrine resistance	8/206	124/7206	0.0253624623367
ko04721	Synaptic vesicle cycle	6/206	80/7206	0.0264510058174
ko04914	Progesterone-mediated oocyte maturation	7/206	104/7206	0.0290027308289
ko00513	Various types of N-glycan biosynthesis	4/206	42/7206	0.0311246039837
ko04973	Carbohydrate digestion and absorption	4/206	42/7206	0.0311246039837
ko00515	Mannose type O-glycan biosynthesis	3/206	25/7206	0.0333386593917
ko04918	Thyroid hormone synthesis	6/206	86/7206	0.0360131793238
ko04917	Prolactin signaling pathway	6/206	87/7206	0.0377968860614
ko04662	B cell receptor signaling pathway	6/206	88/7206	0.0396361886862
ko04270	Vascular smooth muscle contraction	9/206	154/7206	0.0430349308088
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	3/206	28/7206	0.044631773644
ko05166	HTLV-I infection	14/206	292/7206	0.0485797481685